Skip to contentNussbaum Ran — ARQULE INC insider: 164 transactions · InsiderLensNussbaum Ran
- 10% owner at LB PHARMACEUTICALS INC · on record since Sep 11, 2025
- 10% owner at LAURIER INTERNATIONAL INC · on record since Sep 8, 2016
- Director at Kite Pharma, Inc. · on record since Jun 27, 2014
- Director at LB PHARMACEUTICALS INC · on record since Jun 5, 2026
- Director at PAULSON CAPITAL CORP · on record since Oct 31, 2017
- Director at SENESCO TECHNOLOGIES INC · on record since Dec 29, 2017
- Director at ARQULE INC · on record since Nov 20, 2017
- Director at UroGen Pharma Ltd. · on record since Jan 10, 2019
- Director at Prevail Therapeutics Inc. · on record since Jun 19, 2019
- Director at Keros Therapeutics, Inc. · on record since Apr 13, 2020
- 10% owner at Keros Therapeutics, Inc. · on record since Apr 13, 2020
Insider trading activity of Nussbaum Ran
- Transactions on record
- 164
- since Jun 27, 2014
- Open-market buys
- 35
- $40M
- Open-market sells
- 11
- $28.6M
- Companies traded
- 7
- last filing Jun 5, 2026
Figures computed from official regulatory filings — methodology.
Companies where Nussbaum Ran has traded
Track record of Nussbaum Ran
Statistical track record
Free- Open-market buys
- 35
- Last buy
- Sep 12, 2025
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Nussbaum Ran
Co-insiders of Nussbaum Ran
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Opko Health, Inc.PAULSON CAPITAL CORP +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 5, 2026 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Sep 16, 2025 | OtherD | -10,000,000 | — | — | SEC |
| Sep 16, 2025 | Other | 411,681 | — | — | SEC |
| Sep 16, 2025 | Buy | 1,000,000 | 15.00 USD | $15M | SEC |
| Sep 12, 2025 | AwardD | 22,449 | 0.00 USD | $0 | SEC |
| Jun 6, 2025 | Award | 5,250 | 0.00 USD | $0 | SEC |
| Jun 6, 2025 | AwardD | 10,500 | 0.00 USD | $0 | SEC |
| Jun 3, 2024 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Jun 8, 2023 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Feb 28, 2023 | Exercise | 2,211 | 5.00 USD | $11.1K | SEC |
| Feb 28, 2023 | ExerciseD | -15,276 | 0.00 USD | $0 | SEC |
| Feb 28, 2023 | ExerciseD | -1,030 | 0.00 USD | $0 | SEC |
| Feb 28, 2023 | ExerciseD | -2,211 | 0.00 USD | $0 | SEC |
| Feb 28, 2023 | Exercise | 1,030 | 5.00 USD | $5.2K | SEC |
| Feb 28, 2023 | Exercise | 47,999 | 5.94 USD | $285.1K | SEC |
| Feb 28, 2023 | ExerciseD | -32,723 | 0.00 USD | $0 | SEC |
| Nov 30, 2022 | Other | -3,539 | 0.00 USD | $0 | SEC |
| Nov 30, 2022 | Other | -1,723 | 0.00 USD | $0 | SEC |
| Nov 30, 2022 | OtherD | -1,914 | 0.00 USD | $0 | SEC |
| Nov 30, 2022 | OtherD | -1,723 | 0.00 USD | $0 | SEC |
| Nov 30, 2022 | OtherD | -3,539 | 0.00 USD | $0 | SEC |
| Nov 30, 2022 | Other | -1,914 | 0.00 USD | $0 | SEC |
| Aug 25, 2022 | ExerciseD | -1,030 | 0.00 USD | $0 | SEC |
| Aug 25, 2022 | Exercise | 1,030 | 5.00 USD | $5.2K | SEC |
| Jun 17, 2022 | AwardD | 20,000 | 0.00 USD | $0 | SEC |